Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

PROSEVO Trial (Propofol-Sevoflurane Delirium Target Trial Emulation)

3. juni 2026 oppdatert av: Claudia Spies, Charite University, Berlin, Germany

The results of this study have significant implications for clinical practice and guideline development. The current European guideline on postoperative Delirium prevention (ESAIC 2024) explicitly identifies a lack of large, adequately powered studies comparing different anesthetic techniques and is therefore currently unable to provide clear recommendations on the selection of an optimal technique. This study will close this knowledge gap and thus support future guideline recommendations. The results could show that a particular anesthetic technique (e.g., propofol) is associated with a significantly lower risk of postoperative delirium; if so, this would have immediate implications for modifying standard anesthesia protocols in hospitals.

Furthermore, Delirium is a significant public health challenge in aging societies. With demographic aging, the number of older patients undergoing surgery is continuously increasing. The societal costs of Delirium are estimated at several billion euros per year in major industrialized nations. A reduction in the incidence of postoperative Delirium by just 10% through optimization of the anesthetic procedure would therefore have major health economic implications.

Studieoversikt

Status

Rekruttering

Detaljert beskrivelse

This retrospective, single-center cohort study analyzes routine data from Charité - Universitätsmedizin Berlin and its clinical partners for the period from January 1, 2011, to January 31, 2026.

Studietype

Observasjonsmessig

Registrering (Antatt)

100000

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

      • Berlin, Tyskland, 12203
        • Rekruttering
        • Department of Anesthesiology and Intensive Care Medicine (CBF), Charité - Universitätsmedizin Berlin
        • Hovedetterforsker:
          • Sascha Treskatsch, MD, Prof.
        • Ta kontakt med:
      • Berlin, Tyskland, 13353
        • Rekruttering
        • Department of Anesthesiology and Intensive Care Medicine Berlin
        • Hovedetterforsker:
          • Claudia Spies, MD, Prof.
        • Ta kontakt med:
          • Claudia Spies, MD, Prof.
        • Underetterforsker:
          • Maximilian Markus, MD
        • Underetterforsker:
          • Hannah Zoe Wurm
        • Underetterforsker:
          • Nils Daum, MD

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

N/A

Prøvetakingsmetode

Sannsynlighetsprøve

Studiepopulasjon

  • Adult patients (≥18 years) at the Department of Anesthesiology and Intensive Care Medicine (CCM/CVK) and the Department of Anesthesiology and Intensive Care Medicine (CBF) at Charité,
  • undergoing elective surgery under general anesthesia
  • with a planned surgery duration of ≥ 30 minutes

Beskrivelse

Inclusion Criteria:

  • Adult patients (≥18 years) at the Department of Anesthesiology and Intensive Care Medicine (CCM/CVK) and the Department of Anesthesiology and Intensive Care Medicine (CBF) at Charité,
  • undergoing elective surgery under general anesthesia
  • with a planned surgery duration of ≥ 30 minutes

In addition, the following conditions must be met:

  • The surgery must be the patient's first surgery per hospital stay to avoid dependencies and repeated measurements of the same person within a short time frame;
  • The surgeries take place at Charité between January 1, 2011, and December 31, 2025.

Exclusion Criteria:

Patients in any of the following situations are excluded:

  1. Cardiac surgery (this patient group requires specialized monitoring strategies and has postoperative delirium risk profiles that differ significantly from those of other types of surgery)
  2. preoperatively diagnosed delirium, defined as positive results on the Nursing Delirium Screening Scale (NU-DESC) or the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) during preoperative evaluations;
  3. severe preoperative cognitive impairment, defined as a Mini-Mental State Examination (MMSE) score <15 points, or
  4. preoperatively documented severe dementia
  5. neurosurgical procedures (neurosurgical patients require specialized monitoring protocols and differ from other surgical patients in their postoperative delirium (POD) symptoms)
  6. Patients who were already admitted to intensive care units prior to their elective surgery (these patients already have increased mortality and a different risk profile)
  7. Patients who were already intubated or sedated prior to surgery (this group cannot undergo standardized POD screening)
  8. High preoperative risk for postoperative nausea and vomiting (PONV) (specifically, patients with documented PONV grade 3 or PONV grade 4 risk are excluded, as this group is indicated for anesthesia with propofol)

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Incidence of postoperative delirium I
Tidsramme: 01.01.2011 - 31.12.2025
The occurrence of postoperative delirium (yes/no) within the 5-day follow-up period, defined as a positive NU-DESC or CAM-ICU test result on at least one day of hospitalization.
01.01.2011 - 31.12.2025

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Incidence of postoperative delirium II
Tidsramme: 01.01.2011 - 31.12.2025
Incidence of postoperative delirium specifically in the recovery room
01.01.2011 - 31.12.2025
Delirium severity
Tidsramme: 01.01.2011 - 31.12.2025
Delirium severity according to the Delirium Detection Score (DDS)
01.01.2011 - 31.12.2025
Duration of delirium
Tidsramme: 01.01.2011 - 31.12.2025
Number of days with positive delirium screening results
01.01.2011 - 31.12.2025
Time to first occurrence of postoperative delirium
Tidsramme: 01.01.2011 - 31.12.2025
Time to first occurrence of delirium in days after surgery
01.01.2011 - 31.12.2025
Length of hospital stay
Tidsramme: 01.01.2011 - 31.12.2025
Length of hospital stay in days
01.01.2011 - 31.12.2025
Unplanned intensive care unit admission
Tidsramme: 01.01.2011 - 31.12.2025
Unplanned ICU admission by hospital records
01.01.2011 - 31.12.2025
30-day mortality
Tidsramme: 01.01.2011 - 31.01.2026
30-day mortality by hospital records
01.01.2011 - 31.01.2026

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studieleder: Claudia Spies, MD, Prof., Charite University, Berlin, Germany

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

3. juni 2026

Primær fullføring (Antatt)

1. desember 2027

Studiet fullført (Antatt)

1. desember 2027

Datoer for studieregistrering

Først innsendt

21. mai 2026

Først innsendt som oppfylte QC-kriteriene

21. mai 2026

Først lagt ut (Faktiske)

28. mai 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

4. juni 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

3. juni 2026

Sist bekreftet

1. juni 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere